Last reviewed · How we verify
Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia (FINLEVO)
To study whether fluoroquinolone (trovafloxacin or levofloxacin), added to standard treatment, could reduce the high mortality and complication rates in Staphylococcus aureus bacteremia.
Details
| Lead sponsor | University of Helsinki |
|---|---|
| Status | COMPLETED |
| Enrolment | 430 |
| Start date | 1999-01 |
| Completion | 2002-08 |
Conditions
- Staphylococcus Aureus
- Bacteremia
- Endocarditis
- Sepsis
Interventions
- trovafloxacin and levofloxacin
Primary outcomes
- Case fatality rate — At 28 days and at 3 months
Countries
Finland